Login to Your Account



Bone Care Acquired For $600M As Addition to Genzyme Renal

By Karen Pihl-Carey


Thursday, May 5, 2005
Signing a definitive merger agreement, Genzyme Corp. plans to buy out Bone Care International Inc. for about $600 million in cash. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription